Clinical Trials Browser

INDUSTRY × TNBC × 90 days × Clear all

NCT07376629 2026-01-29

A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC

Phase 2 Enrolling by invitation

TNBC